Information:
Error:
ID
14000
Description
Crizotinib Plus Pembrolizumab In Alk-positive Advanced Non Small Cell Lung Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02511184
Link
https://clinicaltrials.gov/show/NCT02511184
Keywords
Versions (1)
- 3/21/16 3/21/16 -
Uploaded on
March 21, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility ALK-positive Advanced NSCLC NCT02511184
Eligibility ALK-positive Advanced NSCLC NCT02511184
- StudyEvent: Eligibility
Similar models
Eligibility ALK-positive Advanced NSCLC NCT02511184
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Non-Small Cell Lung Carcinoma
Item
histologically or cytologically proved diagnosis of locally advanced recurrent or metastatic non-squamous nsclc that is not suitable for local curative treatment.
boolean
C0007131 (UMLS CUI [1])
Alk-positive nsclc
Item
alk-positive nsclc as determined by a test that is approved or validated for use as a companion diagnostic test.
boolean
C3888914 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,2])
Neoplasm Metastasis
Item
no prior systemic therapy for metastatic disease.
boolean
C0027627 (UMLS CUI [1])
Adjuvant chemotherapy
Item
adjuvant chemotherapy more than 12 months prior to study enrollment.
boolean
C0085533 (UMLS CUI [1])
Measurable Disease
Item
Measurable disease as per recist 1.1
boolean
C1513041 (UMLS CUI [1])
ECOG
Item
Ecog ps 0 or 1.
text
C1520224 (UMLS CUI [1])
ALK receptor tyrosine kinase assay
Item
prior exposure to alk receptor tyrosine kinase inhibitor, anti-pd1, anti-pdl1 or any drug targeting t-cell checkpoint pathways.
boolean
C3203742 (UMLS CUI [1])
Immunologic Deficiency Syndromes
Item
Known diagnosis of immunodeficiency or is receiving systemic steroid therapy or other form of immunosuppressive therapy within 7 days of clinical trial treatment.
boolean
C0021051 (UMLS CUI [1])
C4039704 (UMLS CUI [2])
C4039704 (UMLS CUI [2])
Autoimmune Diseases
Item
Active autoimmune disease that has required systemic treatment in the past 3 months.
boolean
C0004364 (UMLS CUI [1])
Lung Diseases
Item
history of extensive disseminated interstitial fibrosis or any grade of interstitial lung disease.
boolean
C0206062 (UMLS CUI [1])